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ABSTRACT
The nuclease-based gene editing tools are rapidly
transforming capabilities for altering the genome of
cells and organisms with great precision and in high
throughput studies. A major limitation in application
of precise gene editing lies in lack of sensitive and
fast methods to detect and characterize the induced
DNA changes. Precise gene editing induces double-
stranded DNA breaks that are repaired by error-prone
non-homologous end joining leading to introduction
of insertions and deletions (indels) at the target site.
These indels are often small and difficult and labori-
ous to detect by traditional methods. Here we present
a method for fast, sensitive and simple indel detec-
tion that accurately defines indel sizes down to ±1
bp. The method coined IDAA for Indel Detection by
Amplicon Analysis is based on tri-primer amplicon
labelling and DNA capillary electrophoresis detec-
tion, and IDAA is amenable for high throughput anal-
ysis.
INTRODUCTION
The emerging gene targeting technologies for precise edit-
ing of higher eukaryote genomes such as zinc finger nucle-
ases (1,2) (ZFNs), transcription activator–like effector nu-
cleases (3,4) (TALENs), RNA-guided clustered regularly
interspaced short palindromic repeats (5,6) (CRISPRs) or
Meganucleases (7,8), have revolutionized genome research
and enabled studies previously limited to prokaryotes and
yeast. These nuclease-based gene editingmethods introduce
double-stranded DNA breaks and lead to a variety of rear-
rangements at the breakpoint mediated by cellular repair
events including non-homologous end-joining (NHEJ) and
homologous recombination (9). In contrast to the speed by
which these editing tools are being optimized and strate-
gies for high throughput use in whole-genome screens are
devised (10,11), considerably less focus are being devoted
to improving capabilities for detection and characteriza-
tion of the induced indels at the specific breakpoint as
well as at potential off-targets. Current approaches avail-
able for identification of indels include: (i) enzyme mis-
match cleavage (EMC) assays, which do not provide sen-
sitive, reliable and accurate identification of the induced in-
del’s (12); and (ii) Sanger or next generation DNA sequenc-
ing, which is costly, time and labour intensive and poorly
suited for high throughput screening of hundreds or thou-
sands of clones often required to select for desirable multi-
allelic editing events that often occur at low frequency.Here,
we report a novel strategy that combines use of a simple am-
plicon labelling strategywith the high throughput capability
of DNA fragment analysis by automated Capillary Elec-
trophoresis (13) for simple detection and characterization
of indels induced by precise gene targeting. The strategy is
coined IDAA for Indel Detection by Amplicon Analysis,
and we demonstrate that IDAA is suitable for detecting in-
dels in both cell pools with low efficiency targeting and sin-
gle sorted cells. Furthermore, we show that IDAA is ideally
suited for high throughput detection of indels down single
base events, estimation of ‘cutting’ efficiencies of targeting
tools and evaluation of off-target events at candidate loci.
MATERIALS AND METHODS
Precise gene targeting induced indel detection by amplicon
analysis (IDAA)
IDAA primers and other primers were obtained from
TAG Copenhagen A/S, Denmark (http://tagc.com/). Am-
plicons were fluorophore labelled by tri-primer amplifi-
cation using a universal 6-FAM 5′-labelled primer FamF
and primers flanking the gene editing target site of which
the sense primer carried an FamF target sequence exten-
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sion. All IDAA assay primers used can be seen in Supple-
mentary Table S1. Optimal tri-primer generated amplicon
yields were observed using a PCR primer ratio of 10:1:10
(FamF:XF:XR) X being either hCOSMC, hGALNT6,
hKRAS, mCosmc, cSt6galnac2 or cCosmc (h = human,
m = murine, c = Chinese hamster ovary (CHO)). PCR
was performed in 25l, using AmpliTaq Gold (ABI/Life
Technologies, USA) or TEMPase Hot Start DNA Poly-
merase (Amplicon, Denmark), 0,5 M:0.05 M:0.5 M
(FamF:F:R) primers and a touchdown thermocycling pro-
file using an initial 72◦C annealing temperature ramping
down by 1 degree/cycle to 58◦C, followed by an additional
25 cycles using 58◦C annealing temperature. Denaturion
and elongation was performed at 95◦C for 45 s and 72◦C
for 30 s respectively. 1ul of the PCR reaction or dilutions
hereof was mixed with 0.5 l LIZ600 or LIZ500 size stan-
dard (ABI/Life Technologies, USA) and applied to frag-
ment analysis onABI3010 sequenator (ABI/Life Technolo-
gies, USA) using conditions recommended by the manufac-
turer. Raw data obtained were analysed using Peak Scanner
Software V1.0 (ABI/Life Technologies, USA).
Gene targeting plasmids and dual ZFN plasmid construction
CompoZr R© ZFN plasmids for hC1GALT1C1/COSMC,
mC1galt1c1/Cosmc and hGALNT6 were obtained from
Sigma (Sigma-Aldrich, St. Louis, MO, USA). GeneArt R©
TALEN cSt6galnc2 plasmids were obtained fromLifeTech-
nologies (Thermo Fisher Scientific Inc, Waltham, MA,
USA). Cas9 plasmid was codon optimized for CHO ex-
pression. Four CHOCosmc gRNA targets were selected us-
ing a tool developed for CHO Cas9/gRNA target predic-
tion (http://staff.biosustain.dtu.dk/laeb/crispy/). All Cas9
and gRNA plasmids used were generously supplied to us by
Lasse Ebdrup Pedersen (Novo Nordisk Foundation Cen-
ter for Biosustainability) except for pCMV-Cas9-GFP ex-
pressing gRNA for KRAS described previously (14). Dual
GALNT6 expression vector was constructed as follows:
GFP and the two GALNT6 ZFN1/2 sequences were fused
via 2A peptide as outlined in Figure 4a. In brief, a sequence
encoding GFP, Flag and nuclear localization signal (NLS)
was inserted in frame into the EcoRI/KpnI site of the
CompoZr R© GALNT6 ZFN-2 plasmid leaving GFP fused
via 2A peptide, Flag andNLS to theGALNT6ZFN-2ORF
as described. A full sequence of codon optimized GALNT6
ZFN-1 (Genewiz, South Plainfield, NJ, USA) fused to se-
quences encoding 2A peptide, 2xmyc tag and a nuclear
localization signal (NLS) was directionally inserted into
the KpnI site, generating GFP-2A-GALNT6-ZFN-1-2A-
ZFN-2 (Dual-GALNT6-ZFN). All plasmids were Sanger
sequenced. Expression and efficient 2A peptide cleavage of
ZFNs were verified by SDS-PAGE Western analysis using
immune reagents to the GFP, ZFN1 (Flag-tag) and ZFN2
(myc-tag) as illustrated in Figure 4b.
Cell culture, transfections and FACS sorting
HeLa, DE4, HEK293AC2, mouse MC57 cells were cul-
tured in Dulbecco’s modified Eagle’s medium with 10%
FBS and 1% L-glutamine, and K562 cells were cultured
in Iscove’s modified Dulbecco’s medium, 10% FBS and
1% L-glutamine. CHO cells were cultured in ex-Cell-CD
media (Sigma Aldrich, USA) with 2% L-glutamine. Cells
were nucleofected using solution kits T and V (K562)
(Lonza, USA) and a Amaxa R© Cell Line Nucleofector R©
device as previously described (15,16) using protocols
provided by Lonza (http://www.lonzabio.com/resources/
product-instructions/protocols/). In brief, 1× 106 cells were
transfected with 2 g of ZFN or TALEN plasmid pairs
or 2 g of Dual-GALNT6-ZFN. For CRISPR/Cas9 CHO
Cosmc targeting, 2 g Cas9 and gRNA plasmids were
nucleofected, and for pCMV-Cas9-GFP expressing KRAS
gRNA 2 g plasmid was used. Cells were exposed to a cold
shock 30◦C for 2 days post-transfection, and incubated one
day at 37◦C after which DNA of the cell pool was pre-
pared usingNucleospin kit as recommended by the supplier
(Machery-Nagel, USA).
For consecutive targeting of the KRAS locus, K562 cells
were subjected to fluorescence-activated cell sorting (FACS)
3 days after nucleofection for isolation of the 2% most
highly GFP fluorescent cells that were then cultured for
about 1 week. Thereafter, an aliquot of the cell pool was
analysed by IDAA (first hit), whereas the rest of the cells
were subjected to another two rounds of nucleofection and
FACS to produce second and third hit pools, respectively,
Furthermore, after the third hit, cells were also single-cell
plated in 96-well plates and expanded to clonal cell lines.
Direct sanger sequencing
Expanded single cell clones were lysed in the wells using
QuickExtract DNA extraction solution (Sigma-Aldrich,
USA), 1 l lysate was used for target region amplifica-
tion. Amplified products were band purified using Qia-mini
elute purification (Qiagen Inc, USA) and used for Topo-
ligation into pCR4-Topo vector (Invitrogen/Life Technolo-
gies, USA), transformed into MegaXcells (Invitrogen/Life
Technologies, USA) and LB-Streptomycin/Carabenicillin
plated. A custom based direct sequencing protocol was de-
veloped by which large sized single cell colonies were boiled
in 10 l TE for 10 min and 5 l hereof added to BigDye.3.1
reaction (ABI/Life Technologies, USA) and sequenced us-
ing 45x sequencing cycles (BGI Europe, Denmark).
T7EI-nuclease assay
Endonucleolytic heteroduplex DNA cleavage analysis was
performed using T7-nuclease-I (New England Biolabs,
USA) as recommended by the supplier. In brief, heterodu-
plex and/or perfect match amplicons were incubated with
1 l T7nuclease in a 20 l volume at 37◦C for 1 h, followed
by 3% agarose gel GelStar (Lonza, USA) analyses.
SDS-PAGEWestern blotting and immunocytochemistry
K562 cells were nucleofected as described above. After 1,
2 or 5 days, aliquots of the cells were harvested and lysed
in SDS-PAGE sample buffer. The cell lysates were normal-
ized for protein content and equal amounts of protein were
subjected to immunoblotting. Blots were incubated with
primary antibodies to the proteins indicated (beta-Actin:
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Figure 1. Schematic depiction of the IDAA strategy. (a) Precise gene targeting creates double-stranded breaks that through NHEJ introduce indels at the
target site. (b) Tri-primer PCR of the target region accomplished by use of target specific primers (F/R) flanking the target site and a universal 5′-FAM
labelled primer (FamF) specific for a 5′-overhang sequence attached to primer F. Tri-primer PCR results in FAM amplicon labelling. (c) Fluorescently
labelled amplicons containing the indels are detected by fragment analysis. Axis represent fluorescence intensity (FI) and amplicon size in base pairs.
Abcam, cat. number: ab8226; c-Myc: Santa Cruz Biotech-
nology, cat. number: sc-40; Flag: Sigma-Aldrich, cat. num-
ber: F3165) followed by HRP-conjugated secondary anti-
bodies (Dako, Denmark), both for 1 h at room tempera-
ture and finally developed with ECL (Pierce/Thermo Sci-
entific, USA). For immunocytochemistry (ICC), CHO cells
were fixed and stained on Teflon coated slides as previ-
ously described (17). In brief, cells were dried on slides and
incubated overnight, 4◦C, with the monoclonal antibody
5F4, followed by secondary anti-mouse-Ig-FITC incuba-
tion (Dako, Denmark), visualization and imaging by fluo-
rescence microscopy as previously described (17).
RESULTS AND DISCUSSION
IDAA for estimating cutting efficiencies for CRISPR/Cas9-
gRNA designs
The amplicon labelling strategy for evaluation of PCR
product sizes was originally introduced by Oetting et al.
(18), using polyacrylamide gel electrophoresis to resolve
larger size differences in products. The strategy was further
improved by Schuelke (19) using capillary electrophore-
sis for resolving smaller size differences down to ±2 bp
of microsatellite repeats and a similar strategy was also
used by Mellersh et al. (20). Here, we built further on this
strategy and advanced the detection resolution down to
a single base pair size discrimination. We used a single-
step tri-primer PCR setup with a universal 6-FAM 5′-
labelled primer (FamF) designed to a specific extension
of the forward target specific primer, which enables one-
step fluorophore labelling of amplicons derived from any
given target using a universal amplification condition (Fig-
ure 1a). In contrast to previous M13 based primer de-
signs (18,19), we used a non-M13 based primer design (5′-
AGCTGACCGGCAGCAAAATTG-3′) increased in se-
quence length (21 versus 18 bases) and G/C content (52%
versus 50%) for 6-FAM labelling, which enables use of
increased assay stringency conditions and results in high
 at D
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Figure 2. Evaluation of IDAA for detection of indels in gene targeted CHO cell pools and derived single clones. (a) IDAA of a pool of CHO cells at day
two after nucleofection with Cas9 and four different gRNA designs targeting Cosmc. Shown from top are IDAA of cell pools transfected with Cas9 alone,
with gRNA1, gRNA2, gRNA3 and gRNA4 (bottom). The position of the unmodified wild-type amplicon peak is indicated (0) and amplicon sizes (in bp)
as determined by Peak Scanner software are indicated below peaks. Indel sizes determined (in bp) are shown above the most prominent peaks together with
cutting efficiencies (calculated from peak area relative to total peak area) in percentage. Total cutting efficiency for gRNA1 and gRNA2 were estimated
to 23% and 46%, respectively, while gRNA3 and gRNA4 were inactive. The relative frequency of indels produced by gRNA2 was confirmed by MiSeq
deep sequencing (Supplementary Figure S6a) which further revealed that the predominant +1 insertion was an thymine insertion at a position three bases
upstream of the PAM sequence. The GSLIZ500 standard peaks are shown in orange. (b) Comparative ICC analysis of the corresponding cell pools shown
in (a) seven days after nucleofection with a monoclonal antibody (5F4) detecting the de novo induction of truncated O-glycans as a result of complete
inactivation of Cosmc (arrow heads indicate single positive cells in pool). (c) Analysis of indels introduced by Sanger sequencing showing distribution in
the −5 bp to +5 bp range of individual single cell clones. (d) Single cell clone Sanger confirmation of the predominant +1 bp indel identified by IDAA. (e)
Representative IDAA analysis of single cell clones showing the 1 bp resolution power of IDAA.
product quality with single peak generation. The tri-primer
amplification assay was standardized and optimized for
general use in detecting a broad range of targets, and op-
timal amplicon yields were obtained using 10:1:10 mo-
lar ratios of 5′-labelled forward primer:unlabelledforward
primer:reverse primer (Figure 1b and Supplementary Table
S1). More than 50 different gene targets in different species
have been profiled using these assay conditions. The fluo-
rophore labelled amplicons can easily be detected with great
sensitivity and with accurate size determination down to±1
bp using standardDNA fragment analysis by capillary elec-
trophoresis methodology (13) (Figure 1c). Importantly, the
method applied enabled unbiased amplicon size discrimi-
nation with crude cell lysates as template source (Figure 3
and Supplementary Figures S1 and S2). To demonstrate
the applicability of the IDAA strategy in nuclease-based
genome editing, we first demonstrate its use for evaluating
cutting efficiencies of CRISPR/Cas9 targeting using four
different gRNA designs (Figure 2a). We targeted theCosmc
gene (X-linked) in CHO cells, because CHO only has one
Cosmc allele and we have a very reliable phenotypic screen
for knockout of Cosmc function (15). We found consistent
 at D
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Figure 3. Distribution of indels found in Cosmc-ZFN targeted single cell FACS sorted MC57 clones. (a) The wild-type allele amplicon is denoted 0 (0 bp
indel), and 81 clones with indels of varying sizes were identified. (b) Comparative IDAA and Sanger sequencing of representative clones. ZFN cutting site
is shown boxed in wt Sanger panel. Indels determined by IDAA are indicated in bp sizes at peaks. For Sanger sequencing the position of the deletion is
indicated with a line in the sequence, insertion is boxed in red. (c) For the larger deletions detected,the sequence of the targeted region is shown above
the IDAA and Sanger panels, with the deleted sequence shown in red. For Sanger sequencing the position of the deletion is indicated with a line in the
sequence.
targeting efficiencies of total cell pools when using either
IDAA or phenotypic screening 3d after transfection with
the constructs (Figure 2b). The IDAA analysis of the total
cell pools and Sanger sequenced single cell clones further-
more revealed that indels ranged from +1 to -13 with an ap-
parent frequency of <1% to a few percent for most of them
(Figure 2a and c). Notably the identity of the predominant
+1 (approximate frequency 20% and 32% for gRNA1 and
gRNA2 respectively) insertion was validated by Sanger and
found to be a T/A base-pair insertion (Figure 2d).
Comparison of IDAA against Sanger sequencing and enzyme
mismatch cleavage assay
We next demonstrated that IDAA is amenable for high
throughput screening of targeted individual cell clones with
a discrimination power down to a single base indel.We used
the same CRISPR/Cas9 Cosmc gRNA2 targeted pool for
single cell cloning shown in Figure 2a, and analysed approx-
imately 200 independent single cell clones by Sanger and
IDAA. Notably, the −5 bp to +5 bp indel distribution ob-
tained by MiSeq next generation deep sequencing (Supple-
mentary Figure S6a) and Sanger was similar to the IDAA
distribution on the cell pool (Figure 2a and c). A variety
of distinct clones with indels ranging from −74 bp to +31
bp were readily identified by IDAA, as exemplified in (Fig-
ure 2e), which also illustrates the 1 bp resolution power of
IDAA for indel genotyping of clones and the ease by which
clones harbouring reading frame-disrupting indels can be
identified. The indels were confirmed by Sanger sequencing
as shown for the predominant +1 insertion identified (Fig-
ure 2d).
To corroborate the usability of IDAA for multi-allele
gene targeting, bi-allelic CHO ST6galnac2 and tri-allelic
human K562 KRAS were targeted with TALEN and
CRISPR/Cas9 nucleases respectively. The IDAA results
for TALEN CHO St6galnac2 two days after transfection
clearly detected indels in the cell pool and successful bi-
allelic targetingwas obtained in a substantial fraction (48%)
of FACS single cell clones analysed (Supplementary Figure
S1a and b). For CRISPR/Cas9 human K562 KRAS tar-
geting, FACS for the 2% most highly fluorescent cells gen-
erated a cell pool (first hit) in which IDAA revealed indels
in the large majority of alleles and only a minor wt peak
(Supplementary Figure S2a). When this pool was subjected
to further two consecutive rounds of targeting and FACS,
IDAA revealed near-complete modification of the KRAS
locus, since the wt peak was hardly detectable. By con-
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Figure 4. Schematic depiction of the labelled ZFN targeting vector for GALNT6 (Dual-GALNT6-ZFN). (a) GFP, 2A peptides (2A1 and 2A2), 3xFLAG
(3xF), nuclear localization signal (NLS), ZFN1 and ZFN2 for GALNT6 (GALNT6ZFN1 & 2), and 3xMyc (3xM) are indicated. (b) SDS-PAGEWestern
blot analysis of K562 cells harvested day 1 (D1), 2 (D2) and 5 (D5) after nucleofection with the Dual-GALNT6-ZFN plasmid targeting vector. Blots were
reacted with anti-GFP, anti-FLAG, anti-Myc or anti-actin antibodies as indicated. Arrow heads indicate reactive bands with expected mobilities. For
control transfections (C) K562 cells were transfected with monomeric Flag-tagged original ZFNs (Sigma-Aldrich) and harvested day 1. (c) IDAA of a
HepG2 cell pool at day 2 post nucleofection with Dual-GALNT6-ZFN. The low efficiency and prevalence of ±1 bp indels were confirmed by MiSeq deep
sequencing (Supplementary Figure S6b). Indel percentages (shown in parenthesis) were calculated from peak areas of the summed indel peaks relative to
the total peak area.
trast, these large modification rates were greatly underesti-
mated by EMC assay (Supplementary Figure S2b). Sanger
sequencing and IDAA analysis of 96 single cell clones iso-
lated from the third hit pool confirmed the indel profile ob-
tained by IDAA on the third hit cell pool and successful tri-
allelic targeting in 99% of the clones was detected by IDAA
(only 1 wt allele was detected) (Supplementary Figure S2c
and d). The IDAA clone analysis in Supplementary Figure
S1b and S2d illustrate the easy by which clones harbouring
reading frame-disrupting indels in all alleles present can be
identified. By contrast, no such information can be derived
from EMC assay, which even fails to detect complete allele
modification in clones, as illustrated in Supplementary Fig-
ure S2b.
We further showed that the IDAA strategy is ideal for
ZFNs, which generally have lower cutting efficiencies. We
first tested a ZFN with medium cutting efficiency (18%
evaluated by an EMC assay, Sigma-Aldrich) targeting the
Cosmc gene in amurine cell line (MC57) (Figure 3).We used
aGFP-taggedZFNapproach that enables FACS sorting for
enrichment of targeting events as recently described (14). A
total of 81 single cell clones derived from 192 FACS seeded
wells were tested by IDAA, and we found complete correla-
tion between the IDAA results and Sanger sequencing. We
then tested aZFNwith low cutting efficiency (2.8% as deter-
mined by an EMC assay, Sigma-Aldrich) targeting the hu-
man GALNT6 (21) gene in human HepG2 cells (Figure 4).
For this we used a novel dual expression plasmid encoding
both ZFNs fused to GFP (Dual-GALNT6-ZFN). We used
IDAA to analyse the cell pool at day two post-transfection,
and we could demonstrate that the predominant targeting
events were ±1 bp indels detectable with around only 1%
 at D
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frequencies. These predominant low targeting events could
also be detected byMiSeq deep sequencing (Supplementary
Figure S6b), but such patterns of targeting events with pre-
dominantly small indels are not expected to be detectable by
the traditional EMC assays. To test this hypothesis, we per-
formed a head-to-head comparison of IDAAwith the most
commonly used indel detection assay. The EMC assay has
been shown to display a preference for heteroduplex DNA
formed by larger deletions rather than single 1 base indels
(12), and it does not provide information on the nature of
the indels and types of alleles present.We first demonstrated
that the EMC assay using T7 endonuclease I easily detected
a large deletion, in this instance induced by a ZFN (Supple-
mentary Figure S3a). We next tested the EMC assay on a
COSMC targeted cell clone with only one allele and pos-
sessing a single base indel. In this case amplicons derived
from the HeLa targeted COSMC allele (22) and wild-type
HeLa cells were mixed and analysed, and we confirm that
whereas larger DNA deletions are easily detected by EMC,
a single base indel is not (Supplementary Figure S3b).
IDAA for detection of candidate off-target indels
Finally, we demonstrate that IDAA is ideally suited for
fast and simple screening for indels in candidate off-target
genes identified by target sequence similarity, which is a ma-
jor concern for all precise gene editing strategies. We first
screened theCHOgenome for themost likely off-target sites
for gRNA2 targeting Cosmc, and identified a total of 189
potential off-targets with two to four bp mismatches (Sup-
plementary Figure S4a). Detailedmismatch distribution for
the top 21 off targets are shown in Supplementary Table S2.
We tested themost likely off-target (2mismatches, no candi-
date genes for gRNA2 with only one mismatch were found)
in 10 independent Cosmc Cas9/gRNA2 targeted single cell
clones by IDAA and we could demonstrate complete ab-
sence of off-target events in all clones (Supplementary Fig-
ure S4b). We next screened additional 20 most likely off-
targets (3–4 mismatches) in all 10 clones, and again con-
firmed complete absence of off-target events in all 10 clones
(Supplementary Figure S5). It should be stressed that our
analysis was conducted on independent cell clones as op-
posed to recent reports where rare off-target effects were
observed in cell pools (10,11).
CONCLUSION
In conclusion, the IDAA strategy presented here enables
sensitive, precise and reliable identification of indels in a
high throughput mode providing detailed information of
cutting efficiency, size and nature of allelic variants gener-
ated by any of the precise gene editing technologies. The
IDAA strategy is user friendly and easily implemented in
any standard laboratory, and we expect that this screening
tool will greatly advance implementation and use of precise
gene targeting.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online.
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